Skip to main content

Annals of Hematology

Ausgabe 6/2012

Inhalt (26 Artikel)

Original Article

Inhibition of p38 MAPK activity promotes ex vivo expansion of human cord blood hematopoietic stem cells

Jing Zou, Ping Zou, Jie Wang, Lei Li, Yong Wang, Daohong Zhou, Lingbo Liu

Open Access Original Article

Intensive consolidation therapy compared with standard consolidation and maintenance therapy for adults with acute myeloid leukaemia aged between 46 and 60 years: final results of the randomized phase III study (AML 8B) of the European Organization for Research and Treatment of Cancer (EORTC) and the Gruppo Italiano Malattie Ematologiche Maligne dell’Adulto (GIMEMA) Leukemia Cooperative Groups

Marysia Hengeveld, Stefan Suciu, Matthias Karrasch, Giorgina Specchia, Jean-Pierre Marie, Petra Muus, Maria C. Petti, Bruno Rotoli, Sergio Amadori, Guiseppe Fioritoni, Pietro Leoni, Enrica Morra, Joseph Thaler, Luigi Resegotti, Paola Fazi, Marco Vignetti, Franco Mandelli, Robert Zittoun, Theo de Witte

Original Article

Rituximab in combination with CHOP chemotherapy for the treatment of diffuse large B cell lymphoma in China: a 10-year retrospective follow-up analysis of 437 cases from Shanghai Lymphoma Research Group

Xiaoyang Li, Zhao Liu, Junning Cao, Xiaonan Hong, Jianmin Wang, Fangyuan Chen, Chun Wang, Shanhua Zou, Junmin Li, Zhixiang Shen

Original Article

The proteasome inhibitor bortezomib targets cell cycle and apoptosis and acts synergistically in a sequence-dependent way with chemotherapeutic agents in mantle cell lymphoma

Grit Hutter, Malte Rieken, Alessandro Pastore, Oliver Weigert, Yvonne Zimmermann, Marc Weinkauf, Wolfgang Hiddemann, Martin Dreyling

Original Article

High prevalence of hepatitis B virus infection in HIV-negative Castleman's disease

Xiang-Gui Yuan, Fei-Fei Chen, Yi-Miao Zhu, Wen Hu, Xiao-Ying Zhao, Jie Jin

Original Article

Chronic lymphocytic leukemia and prolymphocytic leukemia with MYC translocations: a subgroup with an aggressive disease course

Natalie Put, Katrien Van Roosbroeck, Peter Konings, Peter Meeus, Caroline Brusselmans, Katrina Rack, Carine Gervais, Florence Nguyen-Khac, Elise Chapiro, Isabelle Radford-Weiss, Stéphanie Struski, Nicole Dastugue, Nathalie Gachard, Christine Lefebvre, Carole Barin, Virginie Eclache, Sandra Fert-Ferrer, Sophy Laibe, Marie-Joëlle Mozziconacci, Benoît Quilichini, Hélène A. Poirel, Iwona Wlodarska, Anne Hagemeijer, Yves Moreau, Peter Vandenberghe, Lucienne Michaux

Original Article

SIE, SIES, GITMO evidence-based guidelines on novel agents (thalidomide, bortezomib, and lenalidomide) in the treatment of multiple myeloma

Giovanni Barosi, Giampaolo Merlini, Atto Billio, Mario Boccadoro, Paolo Corradini, Monia Marchetti, Massimo Massaia, Patrizia Tosi, Antonio Palumbo, Michele Cavo, Sante Tura

Original Article

Cyclophosphamide-containing regimen (TCD) is superior to melphalan-containing regimen (MPT) in elderly multiple myeloma patients with renal impairment

Moo-Kon Song, Joo-Seop Chung, Ho-Jin Shin, Joon-Ho Moon, Je-Jung Lee, Sung-Soo Yoon, Jin-Seok Kim, Jeong-Ok Lee, Young-Rok Do, Ho-Sup Lee, Eun-Kyung Park

Original Article

Clinical features of adult patients with secondary hemophagocytic lymphohistiocytosis from causes other than lymphoma: an analysis of treatment outcome and prognostic factors

Han-Seung Park, Dae-Young Kim, Je-Hwan Lee, Jung-Hee Lee, Sung-Doo Kim, Young-Hun Park, Jae Seok Lee, Bo Youn Kim, Mijin Jeon, Young-Ah Kang, Young-Shin Lee, Miee Seol, Yeon-Joo Lee, Young-Suk Lim, Seongsoo Jang, Chan-Jeoung Park, Hyun-Sook Chi, Kyoo-Hyung Lee

Original Article

A useful relationship between the presence of extramedullary erythropoeisis and the level of the soluble form of the transferrin receptor in a large cohort of adult patients with thalassemia intermedia: a prospective study

Paolo Ricchi, Massimiliano Ammirabile, Silvia Costantini, Tiziana Di Matola, Roberto Verna, Alvaro Diano, Maria Carmela Foglia, Anna Spasiano, Patrizia Cinque, Luciano Prossomariti

Original Article

Ferroportin (SLC40A1) Q248H mutation is associated with lower circulating serum hepcidin levels in Rwandese HIV-positive women

Florence Masaisa, Candace Breman, Jean Bosco Gahutu, Joshua Mukiibi, Joris Delanghe, Jan Philippé

Original Article

A novel ELISA for diagnosis of Glanzmann’s thrombasthenia and the heterozygote carriers

Vivian Lobo, Shrimati Shetty, Bipin Kulkarni, Kanjaksha Ghosh

Original Article

Imatinib trough plasma levels do not correlate with the response to therapy in patients with chronic myeloid leukemia in routine clinical setting

Edgar Faber, David Friedecký, Kateřina Mičová, Šárka Rožmanová, Martina Divoká, Marie Jarošová, Karel Indrák, Tomáš Adam

Original Article

Allogeneic hematopoietic stem cell transplantation in patients with diffuse large B cell lymphoma relapsed after autologous stem cell transplantation: A GITMO study

Luigi Rigacci, Bendetta Puccini, Anna Dodero, Pasquale Iacopino, Luca Castagna, Stefania Bramanti, Fabio Ciceri, Renato Fanin, Alessandro Rambaldi, Michele Falda, Giuseppe Milone, Stefano Guidi, Massimo Fabrizio Martelli, Patrizio Mazza, Rosi Oneto, Alberto Bosi

Original Article

Concurrent search for unrelated cord and volunteer donor in high-risk acute lymphoblastic leukemia

Anna Paola Iori, Veronica Valle, Alfonso Piciocchi, Giovanna Meloni, Giovanni Fernando Torelli, Antonella Vitale, Anna Maria Testi, Walter Barberi, Roberto Ricci, Filippo Milano, Barbarella Lucarelli, Maria Screnci, Maria Paola Perrone, Luca Laurenti, Fiammetta Natalino, Salvatore Perrone, Nicoletta Sacchi, William Arcese, Roberto Foà

Original Article

Non-atopic IgE and eosinophil cationic protein after allogeneic hematopoietic stem cell transplantation in children

T. Fazekas, N. Pruckner, A. Lawitschka, M. G. Seidel, P. Eickhoff, U. Pötschger, Z. Szépfalusi, H. Gadner, C. Peters

Letter to the Editor

Anemia and global iron fortification and supplementation

Andrew J. Ghio

Letter to the Editor

Mild hepatic iron overload in dysmetabolic hyperferritinemia: MRI may overestimate the liver iron concentration values

Agustin Castiella, Jose M. Alustiza, Eva Zapata, Jose I. Emparanza, Pedro Otazua, Leire Zubiaurre, Alazne Aguirre

Open Access Letter to the Editor

Successful transfusion care for a patient with the Rhesus -D- phenotype and antibodies against Rh17 and two additional alloantibodies

Karen M. K. De Vooght, Ayşe Y. Demir, Claudia C. Folman, Roger E. G. Schutgens, Wouter W. van Solinge, Hans Kemperman

Letter to the Editor

Follicular lymphoma with prominent fibrosis complicated by peripheral eosinophilia

Rie Tabata, Chiharu Tabata, Tomoko Nagai, Ryoji Yasumizu

Letter to the Editor

Secondary haematological malignancies after radioimmunotherapy

Federica Gigli, Angelo Gardellini, Paola Bertazzoni, Giovanni Martinelli

Letter to the Editor

Vincristine-induced vocal cord paralysis in a patient with acute lymphoblastic leukemia

Larry C. Bacon, Michael J. Barnett, Yasser R. Abou Mourad

Letter to the Editor

Extensive bone marrow amyloidosis

Stefano Licci

Letter to the Editor

Lessons from an incidental diagnosis of paroxysmal nocturnal haemoglobinuria

Jecko Thachil, Tim Webster, Richard Kelly, Peter Hillmen, Vanessa Martlew, Anita Hill

Letter to the Editor

Genomic analysis of a four-way t(4;11;22;10) associated with MLL-AF4 in an adult acute lymphoblastic leukemia

Sun Young Cho, Tae Sung Park, Seung Hwan Oh, Eun Hae Cho, Doyeun Oh, Ji Young Huh, Rolf Marschalek, Claus Meyer

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Erhebliches Risiko für Kehlkopfkrebs bei mäßiger Dysplasie

29.05.2024 Larynxkarzinom Nachrichten

Fast ein Viertel der Personen mit mäßig dysplastischen Stimmlippenläsionen entwickelt einen Kehlkopftumor. Solche Personen benötigen daher eine besonders enge ärztliche Überwachung.

Nach Herzinfarkt mit Typ-1-Diabetes schlechtere Karten als mit Typ 2?

29.05.2024 Herzinfarkt Nachrichten

Bei Menschen mit Typ-2-Diabetes sind die Chancen, einen Myokardinfarkt zu überleben, in den letzten 15 Jahren deutlich gestiegen – nicht jedoch bei Betroffenen mit Typ 1.

15% bedauern gewählte Blasenkrebs-Therapie

29.05.2024 Urothelkarzinom Nachrichten

Ob Patienten und Patientinnen mit neu diagnostiziertem Blasenkrebs ein Jahr später Bedauern über die Therapieentscheidung empfinden, wird einer Studie aus England zufolge von der Radikalität und dem Erfolg des Eingriffs beeinflusst.

Costims – das nächste heiße Ding in der Krebstherapie?

28.05.2024 Onkologische Immuntherapie Nachrichten

„Kalte“ Tumoren werden heiß – CD28-kostimulatorische Antikörper sollen dies ermöglichen. Am besten könnten diese in Kombination mit BiTEs und Checkpointhemmern wirken. Erste klinische Studien laufen bereits.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.